Question 1

What are the most cited papers from PEG-Bio Biopharm?

Accepted Answer

The most cited paper from PEG-Bio Biopharm is "A Peptide-Based Magnetic Chemiluminescence Enzyme Immunoassay for Serological Diagnosis of Coronavirus Disease 2019" (Xue-Fei Cai et al., 2020), with 175 citations. Next come "Site‐specific PEGylation of exenatide analogues markedly improved their glucoregulatory activity" (59) and "A Peptide-based Magnetic Chemiluminescence Enzyme Immunoassay for Serological Diagnosis of Corona Virus Disease 2019 (COVID-19)" (40).

Question 2

Which research topics does PEG-Bio Biopharm publish most on?

Accepted Answer

By volume in 2022-now: Glycosylation and Glycoproteins Research, Multiple Myeloma Research and Treatments, Pharmaceutical studies and practices and Acute Lymphoblastic Leukemia research.

Question 3

Which fields of science does PEG-Bio Biopharm work in?

Accepted Answer

In all years, 54% of research at PEG-Bio Biopharm is in Health Sciences, 41% in Life Sciences. Its largest fields are Medicine (54%), Biochemistry, Genetics and Molecular Biology (38%), Chemistry (5%). It does 1.6× the world's share of Health Sciences.

Question 4

Is PEG-Bio Biopharm's research output growing?

Accepted Answer

Output in 2022-2025 was 251% higher than in 2018-2021.